Lataa...
Improving the operational efficiency of Phase 2 and 3 trials
The period toward the end of patients’ participation in late stage blinded clinical trials is highly resource intensive for the sponsor. Consider first a Phase 3 trial. If the trial is a success, the sponsor has to implement the next steps, which might be filing for approval of the drug with the US...
Tallennettuna:
| Julkaisussa: | Trials |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4955134/ https://ncbi.nlm.nih.gov/pubmed/27439520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-016-1465-3 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|